ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
about
Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryEnhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout miceProfiles of multidrug resistance protein-1 in the peripheral blood mononuclear cells of patients with refractory epilepsyReduced small world brain connectivity in probands with a family history of epilepsy.P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human EpilepsyDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersInhibitory RNA in epilepsy: research tools and therapeutic perspectivesPharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsyAntiepileptic drug interactions - principles and clinical implications.Targeting the neurovascular unit for treatment of neurological disorders.ABC transporters: unvalidated therapeutic targets in cancer and the CNSHomeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteinsClinically significant psychotropic drug-drug interactions in the primary care setting.Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgeryRelationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysisRegulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.P-glycoprotein transporter in drug development.ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in miceRole of membrane transporters in the safety profile of drugs.The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.Pharmacogenomics and epilepsy: the road ahead.Methodologies used to identify and characterize interactions among antiepileptic drugs.Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications.Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers.Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells.Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques.Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies.Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer.Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure ratsThe influence of lead on different proteins in gill cells from the freshwater bivalve, Corbicula fluminea, from defense to repair biomarkers.Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.Multidrug resistance proteins expression in glioma patients with epilepsy.
P2860
Q26861408-BD18453C-207E-4CC6-8C6A-F40C7F30DD2BQ28482464-34131F65-55B2-4FA9-931B-D319CFC16AE8Q28483667-507DD520-AC10-4E3D-938A-0526EFAE24C1Q31123801-BCCA96EC-8064-431F-955D-B8B58D465356Q33875127-6EF0D55B-6683-4FEB-BBD9-2285272E9D8AQ33875271-C367A069-76B7-404D-8B74-CAC61C37B47CQ34126428-51427D98-8507-42CF-9E2B-71CC9F493179Q34169804-4F1D7D48-23E5-4D75-93ED-BE625D2CD5B2Q34402188-90EBB045-C80D-4BCB-BFA2-08D167F1D1C7Q34974827-A01F7668-2B69-4908-8FD9-036E9952F058Q35056738-1663D8EB-05A8-45EB-8380-93B650625A1DQ35072901-F63E160A-9D95-4F32-817A-76A8A12F7701Q35094603-51BA2C14-407D-404F-AB16-7A359745F255Q35104220-F3DF6852-CE8B-462B-B581-444E0D634CA2Q35389422-5B1602C0-45C8-4566-BE3C-64C8AA01B9BFQ36281662-E655E288-7C47-4F98-A35F-E5FFBB824B82Q36378047-0EE93BD9-E483-4112-B70F-F78C0A96D350Q36634134-5ADA08CF-95BB-462F-96F1-AFC2F6AE6F3AQ36755799-89BF602A-51A5-405C-805D-F1F6A57564B1Q36954728-619CA9E7-4AA7-4270-AF97-5EF328E3291DQ37575644-3EA6FEE2-1681-4B87-9F09-A90936E45E96Q37587940-A7C96CD6-0D7C-44B9-82EC-21322C5C367EQ37873936-960E403E-2DDC-4310-8AA7-55427069DD8FQ37946957-20A0CCCE-0371-4385-8B0E-CB0ACF833C04Q38018676-ECDE6B7A-09E5-40CF-BD73-9CFFD4381EADQ38071700-24E2BF6E-A9DB-4BD9-84E6-E4713E458F9EQ38803195-D78D397E-C33A-4045-8521-0336185724BFQ38984309-8FE4831B-7FBA-4065-840D-0FBB5BFD05E3Q39270266-E025EE27-2625-427A-BCA8-DD84931B1B08Q39539362-2324BCF9-F00F-4EBD-B81D-2AF6C7E88B94Q39676867-51942873-C7D1-4F8E-8A1D-278939AAA9DFQ40911740-DAE77F9C-59D5-4C76-9C01-DF475073616AQ41808873-24E6208B-8FE1-4C76-9727-F808690F43C1Q42624486-1DA0C64F-8C6A-4930-BB07-A9F4E2089BA3Q42741525-300817AE-5650-4236-95EF-D51BB5FCDD85Q42790208-1B80C7B4-5E16-485C-8D5B-3B3A226AF9A2Q42830808-9E0F9484-5948-4720-997D-AB0C640C8B35Q42935838-4270FE52-A389-4A5F-AB50-D5EA8E134114Q43515674-0733B829-4965-4BF6-989D-E39F096D7C6EQ47340679-351823C1-D285-4AAD-AF84-7AE025D93958
P2860
ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
ABC transporters during epilep ...... stance in refractory epilepsy.
@en
type
label
ABC transporters during epilep ...... stance in refractory epilepsy.
@en
prefLabel
ABC transporters during epilep ...... stance in refractory epilepsy.
@en
P2093
P2860
P1433
P1476
ABC transporters during epilep ...... stance in refractory epilepsy.
@en
P2093
Alberto Lazarowski
Carlos D'Giano
Elena Girardi
Fabiana Lubienieki
Liliana Czornyj
Silvia Vazquez
P2860
P304
P356
10.1111/J.1528-1167.2007.01302.X
P478
48 Suppl 5
P577
2007-01-01T00:00:00Z